Automatic classification of experimental models in biomedical literature to support searching for alternative methods to animal experiments.

Alternatives to animal experiments Corpus annotation Replacement Text classification

Journal

Journal of biomedical semantics
ISSN: 2041-1480
Titre abrégé: J Biomed Semantics
Pays: England
ID NLM: 101531992

Informations de publication

Date de publication:
01 09 2023
Historique:
received: 15 07 2022
accepted: 29 07 2023
medline: 4 9 2023
pubmed: 2 9 2023
entrez: 1 9 2023
Statut: epublish

Résumé

Current animal protection laws require replacement of animal experiments with alternative methods, whenever such methods are suitable to reach the intended scientific objective. However, searching for alternative methods in the scientific literature is a time-consuming task that requires careful screening of an enormously large number of experimental biomedical publications. The identification of potentially relevant methods, e.g. organ or cell culture models, or computer simulations, can be supported with text mining tools specifically built for this purpose. Such tools are trained (or fine tuned) on relevant data sets labeled by human experts. We developed the GoldHamster corpus, composed of 1,600 PubMed (Medline) articles (titles and abstracts), in which we manually identified the used experimental model according to a set of eight labels, namely: "in vivo", "organs", "primary cells", "immortal cell lines", "invertebrates", "humans", "in silico" and "other" (models). We recruited 13 annotators with expertise in the biomedical domain and assigned each article to two individuals. Four additional rounds of annotation aimed at improving the quality of the annotations with disagreements in the first round. Furthermore, we conducted various machine learning experiments based on supervised learning to evaluate the corpus for our classification task. We obtained more than 7,000 document-level annotations for the above labels. After the first round of annotation, the inter-annotator agreement (kappa coefficient) varied among labels, and ranged from 0.42 (for "others") to 0.82 (for "invertebrates"), with an overall score of 0.62. All disagreements were resolved in the subsequent rounds of annotation. The best-performing machine learning experiment used the PubMedBERT pre-trained model with fine-tuning to our corpus, which gained an overall f-score of 0.83. We obtained a corpus with high agreement for all labels, and our evaluation demonstrated that our corpus is suitable for training reliable predictive models for automatic classification of biomedical literature according to the used experimental models. Our SMAFIRA - "Smart feature-based interactive" - search tool ( https://smafira.bf3r.de ) will employ this classifier for supporting the retrieval of alternative methods to animal experiments. The corpus is available for download ( https://doi.org/10.5281/zenodo.7152295 ), as well as the source code ( https://github.com/mariananeves/goldhamster ) and the model ( https://huggingface.co/SMAFIRA/goldhamster ).

Identifiants

pubmed: 37658458
doi: 10.1186/s13326-023-00292-w
pii: 10.1186/s13326-023-00292-w
pmc: PMC10472567
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Bioinformatics. 2016 Jan 15;32(2):276-82
pubmed: 26428294
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
Altern Lab Anim. 2021 Jul;49(4):133-136
pubmed: 34581190
Nucleic Acids Res. 2020 Jul 2;48(W1):W5-W11
pubmed: 32383756
BMC Bioinformatics. 2010 Feb 11;11:85
pubmed: 20149233
Bioinformatics. 2022 Oct 14;38(20):4837-4839
pubmed: 36053172
ALTEX. 2009;26(1):17-31
pubmed: 19326030
Nucleic Acids Res. 2019 Jul 2;47(W1):W587-W593
pubmed: 31114887
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
PLoS One. 2013 Jun 18;8(6):e65390
pubmed: 23823062
J Biomol Tech. 2018 Jul;29(2):25-38
pubmed: 29805321
Nucleic Acids Res. 2012 Jan;40(Database issue):D136-43
pubmed: 22139910
Bioinformatics. 2014 Mar 15;30(6):868-75
pubmed: 24162468
Bioinformatics. 2020 Feb 15;36(4):1234-1240
pubmed: 31501885

Auteurs

Mariana Neves (M)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany. Mariana.Lara-Neves@bfr.bund.de.

Antonina Klippert (A)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Current affiliation: Nuvisan ICB GmbH, Müllerstraße 178, 13353, Berlin, Germany.

Fanny Knöspel (F)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Juliane Rudeck (J)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Ailine Stolz (A)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Zsofia Ban (Z)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Markus Becker (M)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Kai Diederich (K)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Barbara Grune (B)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Pia Kahnau (P)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Nils Ohnesorge (N)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Johannes Pucher (J)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Gilbert Schönfelder (G)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Bettina Bert (B)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Daniel Butzke (D)

German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH